Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines

Journal of Laboratory and Clinical Medicine

Volumn 145, Issue 4, 2005, Pages 212-220

  Specchia, Giorgina ^a   Buquicchio, Caterina ^b   Pansini, Nicola ^b   Di Serio, Francesca ^b   Liso, Vincenzo ^b   Pastore, Domenico ^b   Greco, Giuseppina ^b   Ciuffreda, Lucia ^b   Mestice, Anna ^b   Liso, Arcangelo ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTHRAQUINONE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; CYTARABINE; DAUNORUBICIN; DIGITALIS GLYCOSIDE; DIURETIC AGENT; ETOPOSIDE; IDARUBICIN; ISOENZYME; LACTATE DEHYDROGENASE; MITOXANTRONE; MYOGLOBIN; RETINOIC ACID; TROPONIN I; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOTOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PERICARDITIS; PROTEIN BLOOD LEVEL; TACHYCARDIA;

ADOLESCENT; ADULT; AGED; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; FEMALE; HEART DISEASES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TROPONIN I;

EID: 21044459324     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.02.003     Document Type: Article

References (46)

1. T. Erselcan, K.J.A. Kairemo, T.A. Wiklund, M. Hernberg, C.P. Blomqvist, M. Tenhunen Subclinical cardiotoxicity following adjuvant dose escalated FEC, high-dose chemotherapy, or CMF in breast cancer Br J Cancer 82 2000 777 781
2. W.H. Frishman, H.C. Yee, L.L. Liu Cardiovascular toxicity with cancer chemotheraphy Curr Prob Cardiol 21 1996 225 286
3. J. Wojtacki, E. Lewicka-Nowak, K. Lesniewski-Kmak Anthracycline-induced cardiotoxicity clinical course, risk factors, pathogenesis, detection and prevention--review of the literature Med Sci Monit 6 2000 411 420
4. B. Mladosievicova, I. Hulin, V. Krcmery Jr, H. Petrasova, H. Kollarova Pathogenesis, prevention and detection of cardiotoxicity of anthracycline cytostatic agents Bratisl Lek Listy 95 1994 304 322
5. R. Hrdina, V. Gersl, I. Klimtova, T. Simunek, J. Machackova, M. Adamcova Anthracycline-induced cardiotoxicity Acta Med 43 2000 75 82
6. S.M. Swain, F.S. Whaley, M.S. Ewer Congestive heart failure in patients treated with doxubicin Cancer 97 2003 2869 2879
7. L.C.M. Kremer, M.M.C. Tiel-van Buul, M.C. Ubbink Indium-111 antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children J Clin Oncol 4 1999 1208 1211
8. S.E. Lipshultz, N. Rifai, S.E. Sallan Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury Circulation 96 1997 2641 2648
9. D. Iarussi, P. Indolfi, M. Galderisi, E. Bossone Cardiac toxicity after anthracycline chemotherapy in childhood Herz 25 2000 676 688
10. L. Elbl, V. Chaloupka, I. Vasova, I. Kiss, J. Jancik, J. Vorlicek Changes in left ventricular function during chemotherapy with doxorubucin Vnitr Lek 45 1999 395 402
11. A. Lluch, B. Ojeda, R. Colomer, A. Barnadas, B. Massuti, A. Casado Doxorubicin and placlitaxel in advanced breast carcinoma importance of prior adjuvant anthracycline therapy Cancer 89 2000 2169 2175
12. G.M. Benvenuto, L. La Vecchia, P. Morandi, P. Ruffini, G. Mezzena Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors Ital Heart J 1 2000 1457 1463
13. 2) cyclophosphamide Bone Marrow Trasplant 28 2001 277 282
14. R.J. Cersosimo, W.K. Hong Epirubicin a review of the pharmacology, clinical activity and adverse effects of an adriamycin analogue J Clin Oncol 4 1986 425 439
15. H. Dazzi, K. Kaufmann, F. Follath Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects or documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukemia at the University Hospital of Zurich, Switzerland, between 1990 and 1996 Ann Oncol 12 2001 963 966
16. D. Cardinale, M.T. Sandri, A. Martinoni, E. Borghini, M. Civelli, G. Lamantia Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy Ann Oncol 13 2002 710 715
17. D. Cardinale, M.T. Sandri, A. Martinoni, A. Tricca, M. Civelli, G. Lamantia Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy J Am Coll Cardiol 36 2000 517 522
18. A. Aviles, N. Neri, I. Cuadra, I. Alvarado, S. Cleto Second lethal events associated with treatment for Hodgkin's disease a review of 2980 patients treated in a single Mexican institute Leuk Lymphoma 39 2000 311 319
19. H.W. Auner, R.I. Tinchon, Brezinschek, M. Eibl, S. Sormann, C. Maizen Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high dose cyclophosphamide Eur J Hematol 69 2002 1 6
20. H.W. Auner, C. Tinchon, W. Linkesch, A. Tiran, F. Quehenberger, H. Link Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies Ann Hematol 82 2003 218 222
21. P.K. Singal, N. Illskovic Doxorubicin-induced cardiomyopathy N Engl J Med 339 1998 900 905
22. F.M. Torti, M.M. Bristow, B.L. Lum, S.K. Carter, A.E. Howes, D.A. Aston Cardiotoxicity of epirubicin and doxorubicin assessment by endomyocardial biopsy Cancer Res 46 1986 3722 3727
23. W.I. Ganz, K.S. Sridhar, S.S. Ganz, R. Gonzalez, S. Chakko, A. Serafini Review of tests for monitoring doxorubicin-induced cardiomyopathy Oncology 53 1996 461 470
24. V. Ricchiuti, E.M. Voss, A. Ney, M. Odland, P.A.W. Anderson, F.S. Apple Cardiac troponin T isoforms expressed in renal disease skeletal muscle will not cause false- positive results by the second generation cardiac troponin T assay by Boehringer Mannheim Clin Chem 44 1998 1919 1924
25. M. Muller-Bardorff, K. Hallermayer, A. Schroder, C. Ebert, A. Borgya, W. Gerhardt Improved troponin T Elisa specific for cardiac troponin T isoform assay development and analytical and clinical validation Clin Chem 43 1997 458 466
26. M. Panteghini, F. Pagani, G. Bonetti The sensitivity of cardiac markers an evidence-based approach Clin Chem Lab Med 37 1999 1097 1106
27. E.H. Herman, J. Zhang, S.E. Lipshultz, N. Rifai, D. Chadwick, K. Takeda Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin J Clin Oncol 17 1999 2237 2243
28. E. Missov, C. Calzolari, J.M. Davy, F. Leclercq, M. Rossi, B. Pau Cardiac troponin I in patients with hematologic malignancies Coron Artery Dis 8 1997 537 541
29. J.A. Sparano, A.C. Wolff, D. Brown Troponins for predicting cardiotoxicity from cancer therapy Lancet 356 2000 1947 1948
30. J.M. Bennet, D. Catovsky, M.T. Daniel, G. Flandrin, D.A. Galton, H.R. Gralnick French-American-British (FAB) cooperative group Proposals for the classification of the acute leukemias Br J Haematol 33 1976 451 458
31. M.C. Bene, G. Castoldi, W. Knapp, W.D. Ludwig, E. Matutes, A. Orfao European Group for the Immunological Characterization Of Leukemia (EGIL) Leukemia 9 1995 1783 1786
32. G. Katrukha Aleksei, A.V. Berezikova, V.L. Filatov, T.V. Esakova, O.V. Kolosova Degradation of cardiac troponin I implication for reliable immunodetection Clin Chem 44; 1998 2433 2440
33. M. Panteghini, W. Gerhardt, F.S. Apple, F. Dati, J. Ravkilde, A.H. Wu International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) IFCC Scientific Division Committee on Standardization of Markers of Cardiac Damage Quality specifications for cardiac troponin assays Clin Chem Lab Med 39 2001 174 178
34. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction J Am Coll Cardiol 36 2000 959 969 Eur Heart J 2000;21:1502-13
35. P.B. Gaudin, R.H. Hruban, W.E. Beschorner, E.K. Kasper, J.L. Olson, K.L. Baughman Myocarditis associated with doxorubicin cardiotoxicity Am J Clin Pathol 100 1993 158 163
36. R.W. Carlson Reducing the cardiotoxicity of the anthracyclines Oncology 6 1992 95 107
37. M.T. Meinardi, W.T. Van der Graaf, D.J. van Veldhuisen, J.A. Gietema, E.G. De Vries, D.T. Sleijfer Detection of anthracycline-induced cardiotoxicity Cancer Treat Rev 25 1999 237 247
38. A.H. Wu, L. Ford Release of cardiac troponin in acute coronary syndromes ischemia or necrosis Clin Chim Acta 284 1999 161 174
39. P.O. Collinson, F.G. Boa, D.C. Gaze Measurement of cardiac troponins Ann Clin Biochem 38 2001 423 429
40. D. Wayand, H. Baum, G. Schatzle, J. Scharf, D. Neumeier Cardiac troponin T and I in end stage renal failure Clin Chem 46 2000 1345 1350
41. M. Grenier, S.E. Lipshultz Epidemiology of anthracycline cardiotoxicity in children and adults Semin Oncol 25 4 Suppl 10 1998 72 85
42. J. Li, P.R. Gwilt The effect of age on the early disposition of doxorubicin Cancer Chemother Pharmacol 51 2003 395 402
43. T. Sugimoto, H. Suchimochi, C.G.A. McGregor, H. Mutoh, T. Shimizu, Y. Kurachi Molecular cloning and characterization of the platelet-activating factor gene Res Commun 189 1992 617 624
44. S.B. Ligget, L.E. Wagoner, L.L. Craft, R.W. Hornung, B.D. Hoit, T.C. McIntosh The Ile 164 beta-adrenergic receptor polymorphism adversely affects the outcome of the congestive heart failure J Clin Invest 102 1998 1534 1539
45. D.R. Budman, A. Calabro, W. Kreis In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy time to consider expanded clinical trials? Leukemia 15 2001 1517 1520
46. 2 Ann Oncol 11 2000 1029 1033